Short Interest in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) Increases By 303.8%

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) saw a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 1,579 shares, an increase of 303.8% from the January 29th total of 391 shares. Based on an average daily volume of 2,424 shares, the days-to-cover ratio is presently 0.7 days. Based on an average daily volume of 2,424 shares, the days-to-cover ratio is presently 0.7 days.

Rocket Pharmaceuticals Stock Up 5.4%

RCKTW opened at $0.03 on Friday. The stock’s 50 day moving average price is $0.02 and its two-hundred day moving average price is $0.03. Rocket Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.09.

About Rocket Pharmaceuticals

Rocket Pharmaceuticals, Inc is a clinical-stage biotechnology company focused on developing and commercializing novel, life-transforming gene therapies for rare pediatric diseases. The company’s research and development activities center on inherited genetic disorders, leveraging both lentiviral and adeno-associated virus (AAV) platforms to deliver corrective genes. Rocket’s lead programs include treatments for conditions such as Fanconi anemia, leukocyte adhesion deficiency-I (LAD-I), Danon disease and mucopolysaccharidosis type IIIA (MPS IIIA), each of which represents a high unmet medical need in the pediatric population.

Founded in 2015, Rocket Pharmaceuticals went public in 2018 and trades on the Nasdaq under the ticker symbol RCKTW.